These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 33057072)
21. Ocular surface cytokine profile in chronic Stevens-Johnson syndrome and its response to mucous membrane grafting for lid margin keratinisation. Gurumurthy S; Iyer G; Srinivasan B; Agarwal S; Angayarkanni N Br J Ophthalmol; 2018 Feb; 102(2):169-176. PubMed ID: 28689166 [TBL] [Abstract][Full Text] [Related]
22. Human leukocyte antigen B*0702 is protective against ocular Stevens-Johnson syndrome/toxic epidermal necrolysis in the UK population. Butt GF; Hassan A; Wallace GR; Kinoshita S; Ahmad S; Ueta M; Rauz S Sci Rep; 2021 Feb; 11(1):2928. PubMed ID: 33536518 [TBL] [Abstract][Full Text] [Related]
23. Downregulation of interferon-γ-induced protein 10 in the tears of patients with Stevens-Johnson syndrome with severe ocular complications in the chronic stage. Ueta M; Nishigaki H; Sotozono C; Kinoshita S BMJ Open Ophthalmol; 2017; 1(1):e000073. PubMed ID: 29354711 [TBL] [Abstract][Full Text] [Related]
24. Plasma exosomal Zhang C; Zhu Z; Gao J; Yang L; Dang E; Fang H; Shao S; Zhang S; Xiao C; Yuan X; Li W; Abe R; Qiao H; Wang G; Fu M Sci Transl Med; 2020 Dec; 12(574):. PubMed ID: 33328332 [TBL] [Abstract][Full Text] [Related]
25. Stevens-Johnson syndrome/toxic epidermal necrolysis mouse model generated by using PBMCs and the skin of patients. Saito N; Yoshioka N; Abe R; Qiao H; Fujita Y; Hoshina D; Suto A; Kase S; Kitaichi N; Ozaki M; Shimizu H J Allergy Clin Immunol; 2013 Feb; 131(2):434-41.e1-9. PubMed ID: 23111236 [TBL] [Abstract][Full Text] [Related]
26. Genetic Predisposition to Stevens-Johnson Syndrome With Severe Ocular Surface Complications. Ueta M Cornea; 2015 Nov; 34 Suppl 11():S158-65. PubMed ID: 26448174 [TBL] [Abstract][Full Text] [Related]
27. Association of combined IL-13/IL-4R signaling pathway gene polymorphism with Stevens-Johnson syndrome accompanied by ocular surface complications. Ueta M; Sotozono C; Inatomi T; Kojima K; Hamuro J; Kinoshita S Invest Ophthalmol Vis Sci; 2008 May; 49(5):1809-13. PubMed ID: 18263811 [TBL] [Abstract][Full Text] [Related]
28. Association of human antigen class I genes with cold medicine-related Stevens-Johnson syndrome with severe ocular complications in a Korean population. Jun I; Rim JH; Kim MK; Yoon KC; Joo CK; Kinoshita S; Seo KY; Ueta M Br J Ophthalmol; 2019 Apr; 103(4):573-576. PubMed ID: 30705045 [TBL] [Abstract][Full Text] [Related]
29. Human Leukocyte Antigen Class I Genes Associated With Stevens-Johnson Syndrome and Severe Ocular Complications Following Use of Cold Medicine in a Brazilian Population. Wakamatsu TH; Ueta M; Tokunaga K; Okada Y; Loureiro RR; Costa KA; Sallum JMF; Milhomens JA; Inoue C; Sotozono C; Gomes JÁP; Kinoshita S JAMA Ophthalmol; 2017 Apr; 135(4):355-360. PubMed ID: 28278336 [TBL] [Abstract][Full Text] [Related]
30. Trans-ethnic study confirmed independent associations of HLA-A*02:06 and HLA-B*44:03 with cold medicine-related Stevens-Johnson syndrome with severe ocular surface complications. Ueta M; Kannabiran C; Wakamatsu TH; Kim MK; Yoon KC; Seo KY; Joo CK; Sangwan V; Rathi V; Basu S; Shamaila A; Lee HS; Yoon S; Sotozono C; Gomes JÁ; Tokunaga K; Kinoshita S Sci Rep; 2014 Aug; 4():5981. PubMed ID: 25099678 [TBL] [Abstract][Full Text] [Related]
31. Categorization of the Ocular Microbiome in Japanese Stevens-Johnson Syndrome Patients With Severe Ocular Complications. Ueta M; Hosomi K; Park J; Mizuguchi K; Sotozono C; Kinoshita S; Kunisawa J Front Cell Infect Microbiol; 2021; 11():741654. PubMed ID: 34869055 [TBL] [Abstract][Full Text] [Related]
32. Analysis of differential expression profile of miRNA in peripheral blood of patients with lung cancer. He Q; Fang Y; Lu F; Pan J; Wang L; Gong W; Fei F; Cui J; Zhong J; Hu R; Liang M; Fang L; Wang H; Yu M; Zhang ZF J Clin Lab Anal; 2019 Nov; 33(9):e23003. PubMed ID: 31541491 [TBL] [Abstract][Full Text] [Related]
33. Ocular surface involvement and histopathologic changes in the acute stage of Stevens-Johnson syndrome and toxic epidermal necrolysis: a cross-sectional study. Liu Y; Feng J; Ren Y; Shi W; Kang H; Peng Y; Tan Y; Wu R; Zhang G; He Y BMC Ophthalmol; 2023 Jul; 23(1):297. PubMed ID: 37400766 [TBL] [Abstract][Full Text] [Related]
34. Predictive biomarkers for the progression of ocular complications in chronic Stevens-Johnson syndrome and toxic Eeidermal necrolysis. Yoshikawa Y; Ueta M; Nishigaki H; Kinoshita S; Ikeda T; Sotozono C Sci Rep; 2020 Nov; 10(1):18922. PubMed ID: 33144639 [TBL] [Abstract][Full Text] [Related]
35. The Role of IL-13, IL-15 and Granulysin in the Pathogenesis of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis. Sadek M; Iqbal O; Siddiqui F; Till S; Mazariegos M; Campbell E; Mudaliar K; Speiser J; Bontekoe E; Kouta A; Farooqui A; Daravath B; Qneibi D; Sadek R; Hoppensteadt D; Fareed J; Bouchard C Clin Appl Thromb Hemost; 2021; 27():1076029620950831. PubMed ID: 33560872 [TBL] [Abstract][Full Text] [Related]
36. Association of Human Leukocyte Antigen Class 1 genes with Stevens Johnson Syndrome with severe ocular complications in an Indian population. Kannabiran C; Ueta M; Sangwan V; Rathi V; Basu S; Tokunaga K; Kinoshita S Sci Rep; 2017 Nov; 7(1):15960. PubMed ID: 29162886 [TBL] [Abstract][Full Text] [Related]
37. Prevalence of chronic ocular complications in Stevens-Johnson syndrome and toxic epidermal necrolysis. Van Zyl L; Carrara H; Lecuona K Middle East Afr J Ophthalmol; 2014; 21(4):332-5. PubMed ID: 25371640 [TBL] [Abstract][Full Text] [Related]
38. A cross-sectional comparative study on chronic ocular manifestations of Stevens-Johnson syndrome and toxic epidermal necrolysis in Chinese eyes: a 15-year case series. Chow LLW; Ng ALK; Chow SSW; Choy BNK; Shih KC; Wong IYH; Chan JCY; Lai JSM Int Ophthalmol; 2018 Jun; 38(3):1155-1160. PubMed ID: 28547534 [TBL] [Abstract][Full Text] [Related]
39. Multistep Grading System for Evaluation of Chronic Ocular Sequelae in Patients With Stevens-Johnson Syndrome. Sharma N; Venugopal R; Maharana PK; Chaniyara M; Agarwal T; Pushker N; Pandey RM; Sangwan S; Sen S; Kashyap S; Sharma A; Khanna N; Vajpayee RB Am J Ophthalmol; 2019 Jul; 203():69-77. PubMed ID: 30731084 [TBL] [Abstract][Full Text] [Related]